Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 19 | 2021 | 1092 | 2.450 |
Why?
|
| Repressor Proteins | 6 | 2020 | 273 | 1.400 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2020 | 12 | 1.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2020 | 299 | 1.080 |
Why?
|
| Prostate | 7 | 2014 | 155 | 1.050 |
Why?
|
| S-Phase Kinase-Associated Proteins | 4 | 2015 | 23 | 1.000 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 333 | 0.940 |
Why?
|
| PTEN Phosphohydrolase | 14 | 2018 | 59 | 0.850 |
Why?
|
| Receptors, Androgen | 3 | 2014 | 144 | 0.850 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2014 | 32 | 0.840 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2021 | 968 | 0.800 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 12 | 0.710 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 23 | 0.700 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2013 | 165 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2018 | 9 | 0.580 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 561 | 0.570 |
Why?
|
| Mice | 24 | 2021 | 6644 | 0.550 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2010 | 220 | 0.540 |
Why?
|
| SOX9 Transcription Factor | 2 | 2014 | 10 | 0.530 |
Why?
|
| MicroRNAs | 2 | 2021 | 518 | 0.470 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2013 | 11 | 0.470 |
Why?
|
| Cell Proliferation | 7 | 2021 | 1455 | 0.440 |
Why?
|
| Transcription Factors | 4 | 2014 | 735 | 0.430 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 185 | 0.420 |
Why?
|
| beta Catenin | 1 | 2014 | 78 | 0.410 |
Why?
|
| Cadherins | 1 | 2014 | 102 | 0.400 |
Why?
|
| Disease Progression | 6 | 2021 | 667 | 0.390 |
Why?
|
| Animals | 26 | 2021 | 16992 | 0.380 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 173 | 0.370 |
Why?
|
| Cell Nucleus | 4 | 2018 | 383 | 0.360 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 2676 | 0.350 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2007 | 223 | 0.350 |
Why?
|
| Signal Transduction | 9 | 2021 | 2157 | 0.350 |
Why?
|
| Ubiquitination | 4 | 2015 | 62 | 0.340 |
Why?
|
| Mice, Knockout | 6 | 2020 | 1035 | 0.340 |
Why?
|
| Male | 21 | 2021 | 23409 | 0.340 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2005 | 35 | 0.290 |
Why?
|
| Humans | 24 | 2021 | 43102 | 0.250 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 35 | 0.230 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 665 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2013 | 456 | 0.180 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 12 | 0.180 |
Why?
|
| Ubiquitin | 2 | 2013 | 81 | 0.160 |
Why?
|
| Fibroblasts | 4 | 2010 | 281 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 291 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 290 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1596 | 0.150 |
Why?
|
| Tyrosine | 1 | 2018 | 120 | 0.140 |
Why?
|
| Carbon | 1 | 2018 | 128 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2010 | 1621 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2013 | 986 | 0.130 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 53 | 0.130 |
Why?
|
| Protein Transport | 3 | 2013 | 296 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 1180 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 237 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2015 | 256 | 0.120 |
Why?
|
| Neoplasms | 4 | 2015 | 1377 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 1542 | 0.120 |
Why?
|
| Hazardous Substances | 1 | 2015 | 19 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2011 | 23 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 183 | 0.110 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 16 | 0.110 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 80 | 0.110 |
Why?
|
| Quinolines | 1 | 2013 | 78 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 61 | 0.100 |
Why?
|
| Imidazoles | 1 | 2013 | 142 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 97 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 56 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 934 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2012 | 104 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 157 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 291 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2012 | 53 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 150 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 1082 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 147 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 257 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2009 | 883 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2007 | 91 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 40 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 31 | 0.070 |
Why?
|
| Cytosol | 1 | 2009 | 97 | 0.070 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 8 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2008 | 64 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2009 | 192 | 0.070 |
Why?
|
| Female | 4 | 2015 | 24698 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 2007 | 19 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 60 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2009 | 321 | 0.060 |
Why?
|
| Phenotype | 2 | 2009 | 780 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 14 | 0.060 |
Why?
|
| Tuberous Sclerosis | 1 | 2005 | 1 | 0.060 |
Why?
|
| Haplotypes | 1 | 2005 | 197 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 98 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2005 | 368 | 0.050 |
Why?
|
| Neoplasm Transplantation | 3 | 2010 | 129 | 0.050 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 2 | 2010 | 5 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 29 | 0.040 |
Why?
|
| Hela Cells | 2 | 2012 | 376 | 0.040 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 56 | 0.040 |
Why?
|
| Androgens | 1 | 2018 | 106 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 712 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1869 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2007 | 9 | 0.030 |
Why?
|
| Proteins | 2 | 2009 | 382 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2011 | 1271 | 0.030 |
Why?
|
| Genotype | 2 | 2009 | 800 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 154 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2011 | 18 | 0.020 |
Why?
|
| Histones | 1 | 2012 | 197 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 186 | 0.020 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 98 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 56 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2009 | 17 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 21 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 132 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 95 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 122 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 536 | 0.020 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 61 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 462 | 0.020 |
Why?
|
| Mitosis | 1 | 2009 | 114 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 356 | 0.020 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2007 | 2 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Polyps | 1 | 2007 | 9 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 307 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 51 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 652 | 0.020 |
Why?
|
| Glutamine | 1 | 2007 | 36 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 219 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 182 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 119 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 247 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 423 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 701 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 374 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 21 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 11 | 0.010 |
Why?
|
| Cell Movement | 1 | 2009 | 655 | 0.010 |
Why?
|
| Serine | 1 | 2005 | 79 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 294 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 100 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 223 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 408 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 983 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 196 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 372 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 1177 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 1410 | 0.010 |
Why?
|